Tamboli Ajim bought TRAX

April 21, 2026 · Form 4 insider transaction

Tamboli Ajim bought 45,700 shares of First Tracks Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
45,700
Price
$0.00
Total value
N/A
RoleOfficer
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateApril 21, 2026
Filing dateApril 23, 2026
Shares owned after45,700
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.; 1/4 of the RSUs shall vest on April 20, 2027 and 1/4th of the RSUs shall vest in equal annual installments until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

View the original Form 4 on SEC EDGAR